Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011090220> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2011090220 endingPage "589" @default.
- W2011090220 startingPage "582" @default.
- W2011090220 abstract "Although clinical trials have found that enoxaparin clearance is prolonged in renal impairment, only one letter describes experience with adjusting doses. Only pharmacokinetic studies exist to guide dose adjustment in response to anti-Xa levels. Unfractionated heparin has comparable major bleeding in renal impairment compared with unadjusted enoxaparin. This necessitates a pharmacokinetic program to adjust enoxaparin with anti-Xa monitoring.A pharmacokinetic program was created in response to adverse events and physician interest in a service. A program was designed providing all patients a loading dose of 1 mg/kg enoxaparin. Subsequent doses were 0.50 mg/kg per dose subcutaneously (SC) every 12 hours (q12h) for patients with a creatinine clearance (CrCl) < or =30 mL/min (severe group) and 0.75 mg/kg per dose SC q12h for patients with CrCl of 30 to 60 mL/min (moderate group). A 1-year review of 170 hospitalized patients is reported.The mean +/- SD [95% CI] anti-Xa level 4 hours after the third dose was 0.65 +/- 0.19 [0.59 to 0.70] IU/mL for the severe group and 0.82 +/- 0.18 [0.79 to 0.85] IU/mL for the moderate group (P <.001). Eighty percent of patients with moderate renal failure and 60% of the patients with severe renal failure were in the therapeutic anti-Xa range after the third dose. A dose-adjustment ratio was used to adjust doses in patients whose levels were outside the therapeutic range: New dose = [(Current dose) x (Goal anti-Xa level)]/(Current anti-Xa level). An incidence of bleeding comparable to that found in normal patients was found.In high-risk patients, it is reasonable to limit the exposure of patients to low molecular weight heparins by using anti-Xa levels as a marker. The enoxaparin protocol for renally impaired patients successfully placed patients in the therapeutic range established by consensus guidelines. The dose-adjustment ratio adds significant understanding to the pharmacokinetics of dose adjustment." @default.
- W2011090220 created "2016-06-24" @default.
- W2011090220 creator A5081047570 @default.
- W2011090220 creator A5088188000 @default.
- W2011090220 date "2004-10-01" @default.
- W2011090220 modified "2023-09-27" @default.
- W2011090220 title "Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment" @default.
- W2011090220 cites W1550111394 @default.
- W2011090220 cites W168034184 @default.
- W2011090220 cites W1972760043 @default.
- W2011090220 cites W2026393945 @default.
- W2011090220 cites W2035959805 @default.
- W2011090220 cites W2043340874 @default.
- W2011090220 cites W2045680069 @default.
- W2011090220 cites W2051626799 @default.
- W2011090220 cites W2067753153 @default.
- W2011090220 cites W2073265922 @default.
- W2011090220 cites W2099097580 @default.
- W2011090220 cites W2106194057 @default.
- W2011090220 cites W2107337786 @default.
- W2011090220 cites W2118770994 @default.
- W2011090220 cites W2147828132 @default.
- W2011090220 cites W2153187399 @default.
- W2011090220 cites W2158466772 @default.
- W2011090220 cites W2159553511 @default.
- W2011090220 cites W2171713512 @default.
- W2011090220 cites W2184709903 @default.
- W2011090220 cites W2473039246 @default.
- W2011090220 cites W4211171219 @default.
- W2011090220 doi "https://doi.org/10.1016/j.ahj.2004.04.015" @default.
- W2011090220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15459586" @default.
- W2011090220 hasPublicationYear "2004" @default.
- W2011090220 type Work @default.
- W2011090220 sameAs 2011090220 @default.
- W2011090220 citedByCount "48" @default.
- W2011090220 countsByYear W20110902202012 @default.
- W2011090220 countsByYear W20110902202013 @default.
- W2011090220 countsByYear W20110902202014 @default.
- W2011090220 countsByYear W20110902202015 @default.
- W2011090220 countsByYear W20110902202016 @default.
- W2011090220 countsByYear W20110902202017 @default.
- W2011090220 countsByYear W20110902202018 @default.
- W2011090220 countsByYear W20110902202020 @default.
- W2011090220 countsByYear W20110902202021 @default.
- W2011090220 countsByYear W20110902202022 @default.
- W2011090220 countsByYear W20110902202023 @default.
- W2011090220 crossrefType "journal-article" @default.
- W2011090220 hasAuthorship W2011090220A5081047570 @default.
- W2011090220 hasAuthorship W2011090220A5088188000 @default.
- W2011090220 hasConcept C112705442 @default.
- W2011090220 hasConcept C126322002 @default.
- W2011090220 hasConcept C126894567 @default.
- W2011090220 hasConcept C159641895 @default.
- W2011090220 hasConcept C167135981 @default.
- W2011090220 hasConcept C197934379 @default.
- W2011090220 hasConcept C19831878 @default.
- W2011090220 hasConcept C2776884760 @default.
- W2011090220 hasConcept C2777557582 @default.
- W2011090220 hasConcept C2780035454 @default.
- W2011090220 hasConcept C2780306776 @default.
- W2011090220 hasConcept C27924281 @default.
- W2011090220 hasConcept C71924100 @default.
- W2011090220 hasConcept C98274493 @default.
- W2011090220 hasConceptScore W2011090220C112705442 @default.
- W2011090220 hasConceptScore W2011090220C126322002 @default.
- W2011090220 hasConceptScore W2011090220C126894567 @default.
- W2011090220 hasConceptScore W2011090220C159641895 @default.
- W2011090220 hasConceptScore W2011090220C167135981 @default.
- W2011090220 hasConceptScore W2011090220C197934379 @default.
- W2011090220 hasConceptScore W2011090220C19831878 @default.
- W2011090220 hasConceptScore W2011090220C2776884760 @default.
- W2011090220 hasConceptScore W2011090220C2777557582 @default.
- W2011090220 hasConceptScore W2011090220C2780035454 @default.
- W2011090220 hasConceptScore W2011090220C2780306776 @default.
- W2011090220 hasConceptScore W2011090220C27924281 @default.
- W2011090220 hasConceptScore W2011090220C71924100 @default.
- W2011090220 hasConceptScore W2011090220C98274493 @default.
- W2011090220 hasIssue "4" @default.
- W2011090220 hasLocation W20110902201 @default.
- W2011090220 hasLocation W20110902202 @default.
- W2011090220 hasOpenAccess W2011090220 @default.
- W2011090220 hasPrimaryLocation W20110902201 @default.
- W2011090220 hasRelatedWork W1544023406 @default.
- W2011090220 hasRelatedWork W1830795151 @default.
- W2011090220 hasRelatedWork W1973741567 @default.
- W2011090220 hasRelatedWork W1974378936 @default.
- W2011090220 hasRelatedWork W2000788972 @default.
- W2011090220 hasRelatedWork W2014603468 @default.
- W2011090220 hasRelatedWork W2046899919 @default.
- W2011090220 hasRelatedWork W3117263584 @default.
- W2011090220 hasRelatedWork W393698729 @default.
- W2011090220 hasRelatedWork W4296385806 @default.
- W2011090220 hasVolume "148" @default.
- W2011090220 isParatext "false" @default.
- W2011090220 isRetracted "false" @default.
- W2011090220 magId "2011090220" @default.
- W2011090220 workType "article" @default.